These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long-Term Safety and Efficacy of Perfluorohexyloctane Ophthalmic Solution for the Treatment of Patients With Dry Eye Disease: The KALAHARI Study. Protzko EE; Segal BA; Korenfeld MS; Krösser S; Vittitow JL Cornea; 2024 Sep; 43(9):1100-1107. PubMed ID: 37921522 [TBL] [Abstract][Full Text] [Related]
5. Dry Eye Disease Associated with Meibomian Gland Dysfunction: Focus on Tear Film Characteristics and the Therapeutic Landscape. Sheppard JD; Nichols KK Ophthalmol Ther; 2023 Jun; 12(3):1397-1418. PubMed ID: 36856980 [TBL] [Abstract][Full Text] [Related]
6. Perfluorohexyloctane Eye Drops for Dry Eye Disease Associated With Meibomian Gland Dysfunction in Chinese Patients: A Randomized Clinical Trial. Tian L; Gao Z; Zhu L; Shi X; Zhao S; Gu H; Xu G; Wang L; Dai H; Zhang H; Jin X; Ma K; Xu Y; Ma L; Pei C; Ke B; Krösser S; Zhang Y; Jie Y JAMA Ophthalmol; 2023 Apr; 141(4):385-392. PubMed ID: 36929413 [TBL] [Abstract][Full Text] [Related]
7. NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study. Tauber J; Berdy GJ; Wirta DL; Krösser S; Vittitow JL; Ophthalmology; 2023 May; 130(5):516-524. PubMed ID: 36574848 [TBL] [Abstract][Full Text] [Related]
8. Influence of Perfluorohexyloctane Eye Drops on Tear Film Thickness in Patients with Mild to Moderate Dry Eye Disease: A Randomized Controlled Clinical Trial. Schmidl D; Bata AM; Szegedi S; Aranha Dos Santos V; Stegmann H; Fondi K; Krösser S; Werkmeister RM; Schmetterer L; Garhöfer G J Ocul Pharmacol Ther; 2020 Apr; 36(3):154-161. PubMed ID: 31895638 [No Abstract] [Full Text] [Related]
9. Preclinical studies evaluating the effect of semifluorinated alkanes on ocular surface and tear fluid dynamics. Agarwal P; Khun D; Krösser S; Eickhoff K; Wells FS; Willmott GR; Craig JP; Rupenthal ID Ocul Surf; 2019 Apr; 17(2):241-249. PubMed ID: 30831252 [TBL] [Abstract][Full Text] [Related]
10. A Water-Free Omega-3 Fatty Acid Eye Drop Formulation for the Treatment of Evaporative Dry Eye Disease: A Prospective, Multicenter Noninterventional Study. Jacobi C; Angstmann-Mehr S; Lange A; Kaercher T J Ocul Pharmacol Ther; 2022 Jun; 38(5):348-353. PubMed ID: 35507946 [No Abstract] [Full Text] [Related]
11. In Vitro Inhibition of Evaporation with Perfluorohexyloctane, an Eye Drop for Dry Eye Disease. Vittitow J; Kissling R; DeCory H; Borchman D Curr Ther Res Clin Exp; 2023; 98():100704. PubMed ID: 37389230 [TBL] [Abstract][Full Text] [Related]
12. NOV03 for Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction: The Randomized Phase 3 MOJAVE Study. Sheppard JD; Kurata F; Epitropoulos AT; Krösser S; Vittitow JL; Am J Ophthalmol; 2023 Aug; 252():265-274. PubMed ID: 36948372 [TBL] [Abstract][Full Text] [Related]
13. Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease. Steven P; Augustin AJ; Geerling G; Kaercher T; Kretz F; Kunert K; Menzel-Severing J; Schrage N; Schrems W; Krösser S; Beckert M; Messmer EM J Ocul Pharmacol Ther; 2017 Nov; 33(9):678-685. PubMed ID: 28922088 [TBL] [Abstract][Full Text] [Related]
14. Management Strategies for Evaporative Dry Eye Disease and Future Perspective. Rolando M; Merayo-Lloves J Curr Eye Res; 2022 Jun; 47(6):813-823. PubMed ID: 35521685 [TBL] [Abstract][Full Text] [Related]
15. Varenicline Solution Nasal Spray: A Review in Dry Eye Disease. Frampton JE Drugs; 2022 Sep; 82(14):1481-1488. PubMed ID: 36197638 [TBL] [Abstract][Full Text] [Related]
16. Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study. Zhang Q; Zhang H; Qin G; Wu Y; Song Y; Yang L; Yu S; He X; Moore JE; Moutari S; Palme C; Xu L; He W; Pazo EE J Ocul Pharmacol Ther; 2022 Mar; 38(2):133-140. PubMed ID: 35049373 [No Abstract] [Full Text] [Related]
17. A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease. Tauber J; Wirta DL; Sall K; Majmudar PA; Willen D; Krösser S; Cornea; 2021 Sep; 40(9):1132-1140. PubMed ID: 33369937 [TBL] [Abstract][Full Text] [Related]
18. Objective optical assessment of tear-film quality dynamics in patients with meibomian gland dysfunction and aqueous-deficient dry eye optical quality changes in different dry eye subtypes. Ye F; Jiang F; Lu Y; Xue CY; Zhu XM; Wu Y; Huang ZP Indian J Ophthalmol; 2019 May; 67(5):599-603. PubMed ID: 31007216 [TBL] [Abstract][Full Text] [Related]
19. The effect of hydroxypropyl-guar nanoemulsion on signs and symptoms of dry eye. Markoulli M; Wong K; Jia T; Siddireddy JS; Briggs N; Tan J Cont Lens Anterior Eye; 2022 Dec; 45(6):101736. PubMed ID: 35835650 [TBL] [Abstract][Full Text] [Related]